IDEXX Labs (NASDAQ: IDXX) reported Q4 EPS of $1.89, $0.18 better than the analyst estimate of $1.71. Revenue for the quarter came in at $801 million versus the consensus estimate of $784.27 million.

GUIDANCE:

IDEXX Labs sees FY2022 EPS of $9.27-$9.59, versus the consensus of $9.39.

For earnings history and earnings-related data on IDEXX Labs (IDXX) click here.